Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy-Reference-Cited by-同舟云学术

Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy

Published:2023-09-09 Issue:8 Volume:23 Page:5337-5343
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Ma Qiqi,Li Manna,Xu Gaosi^ORCID

Funder

Jiangxi Graduate Innovation Special Fund

Key Clinical Research Project of the Second Affiliated Hospital of Nanchang University

Thousand Talents Plan” Project of Introducing and Training High‐level Talents of Innovation and Entrepreneurship in Jiangxi Province

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-023-01183-1.pdf

Reference20 articles.

1. Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, Sethi S, Tong A, Vivarelli M, Wetzels J. Membranous nephropathy. Nat Rev Dis Primers. 2021. https://doi.org/10.1038/s41572-021-00303-z.

2. Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, et al. Executive summary of the kdigo 2021 guideline for the management of glomerular diseases. Kidney Int. 2021. https://doi.org/10.1016/j.kint.2021.05.015.

3. Rojas-Rivera JE, Ortiz A, Fervenza FC. Novel treatments paradigms: membranous nephropathy. Kidney Int Rep. 2023. https://doi.org/10.1016/j.ekir.2022.12.011.

4. von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2021. https://doi.org/10.1002/14651858.CD004293.pub4.

5. Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1814427.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. Low risk of hepatitis B virus reactivation in membranous nephropathy patients with resolved infection undergoing rituximab-based regimens without antiviral prophylaxis;International Immunopharmacology;2024-09

3. Rituximab/glucocorticoids;Reactions Weekly;2024-04-27